The final late-breaking abstract deadline of 7 August 2024 isunder no circumstancesto be considered as an extension of the general submission deadline. Trial in progress abstracts (TiP)-进行中的试验摘要 Trial in Progress (TiP) abstracts in all phases of clinical research (phases I to III) ma...
The final late-breaking abstract deadline of 7 August 2024 isunder no circumstancesto be considered as an extension of the general submission deadline. Trial in progress abstracts (TiP)-进行中的试验摘要 Trial in Progress (TiP) abstracts in all phases of clinical research (phases I to III) ma...
The final late-breaking abstract deadline of 17 April 2024 is under no circumstances to be considered as an extension of the general submission deadline (13 February 2024). Trial in Progress abstracts Trial in Progress (TiP) abstracts in all phases of clinical research (phases I to III)...
We look forward to welcoming you again to Lugano in 2024, to share with you the latest original scientific data in these rare sub-entities. Scientific Co-Chairs Jean-Yves Blay, Lyon, France Robin Jones, London, UK Claudia Valverde Morales, Barcelona, Spain 摘要征文投稿: Abstract submission de...
Recruitment must have already begun or have been completed by the abstract submission deadline of 21 February 2023. Abstracts including results or preliminary data will be rejected. Trial in Progress abstracts will be accepted for Poster outcome only. ...
提交指南>>>ESMO Sarcoma and Rare Cancers 2024 Abstract Regulations Submission categories Central Nervous System (CNS) Digestive cancers Genitourinary cancers Gynaecological cancers Head and neck cancers Neuroendocrine and Endocrine cancers Public Policy and Patient Advocacy ...
Abstract submission categories Basic and translational research Cervical cancer Endometrial cancer Ovarian cancer Miscellaneous Outcome notifications Outcome notifications of regular abstracts are expected to be made available to first authors and submitters by beginning of May 2024. ...
The final late-breaking abstract deadline of 6 November 2024 is under no circumstances to be considered as an extension of the general submission deadline (1 October 2024). Trial in Progress abstracts Trial in Progress (TiP) abstracts in all phases of clinical research (phases I to III)...
The final late-breaking abstract deadline of 6 November 2024 is under no circumstances to be considered as an extension of the general submission deadline (1 October 2024). Trial in Progress abstracts Trial in Progress (TiP) abstracts in all phases of clinical research (phases I to III)...
Recruitment must have already begun or have been completed by the abstract submission deadline of Tuesday, 29 November 2022. Abstracts including results or preliminary data will be rejected. Trial in Progress abstracts will be accepted for Poster outcome only. ...